What Abbott does

Abbott Laboratories is a publicly traded (NYSE: ABT) global healthcare and medical technology company headquartered in Abbott Park, Illinois, founded in 1888 and employing approximately 122,000 people across more than 160 countries. Under Chairman and CEO Robert B. Ford (CEO since March 2020, Chairman since December 2021), Abbott operates six core segments: Diabetes Care (FreeStyle Libre continuous glucose monitoring systems and the Lingo consumer biowearable), Diagnostics (Alinity and ARCHITECT laboratory analyzers, BinaxNOW rapid tests, ID NOW molecular platform, and i-STAT point-of-care testing), Cardiovascular and Structural Heart (MitraClip, TriClip, Navitor TAVI, HeartMate 3 LVAD, AVEIR leadless pacemakers, and CardioMEMS HF System), Neuromodulation (Proclaim Plus, Eterna, Infinity DBS, Liberta RC, and NeuroSphere Digital Health), Nutrition (Similac, Ensure, Pedialyte, PediaSure, Glucerna, EleCare, and PROTALITY), and Established Pharmaceuticals focused on emerging markets.

Abbott's technology platform combines factory-calibrated CGM biosensors, transcatheter structural heart devices, integrated clinical chemistry/immunoassay/hematology analyzers, and remote-monitoring digital health tools. Its products serve healthcare providers (hospitals, labs, clinics), prescription and over-the-counter consumer end-markets, and emerging-market patient populations across therapeutic areas including women's health, cardiometabolic, gastroenterology, and oncology.

Abbott generates revenue primarily through hardware sales of medical devices, diagnostic instruments, and nutrition products, distributed via a dual go-to-market model: enterprise field sales teams targeting healthcare providers for high-value devices and prescription products, plus direct-to-consumer channels including the Abbott Store and major retail partners (Amazon, Walmart, Target, CVS) for nutrition, Lingo biosensors, and rapid diagnostic self-tests. Its Lingo product introduces a subscription-like recurring revenue model on top of traditional one-time device sales. Abbott serves more than 2 billion people globally, with 64 million people using its medicines products daily, and operates a Sustainability Plan target to reach 3 billion people annually by 2030.

Name

Abbott

Legal name

Abbott Laboratories

Website

https://abbott.com

Company type

Public

Founded year

1888

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Abbott Laboratories is a global publicly traded medical technology and healthcare company that develops and sells diagnostic systems, cardiovascular and neuromodulation devices, continuous glucose monitors, nutrition products, and emerging-market pharmaceuticals across 160+ countries. It serves healthcare providers and consumers in 2+ billion lives annually.

Ownership category

akta.pro rank

Product category

Medical Devices and Diagnostics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Automated Insulin Delivery (AID) / Closed-Loop Systems (HLAHAHAF)

Keywords

• Medical devices manufacturing
• Continuous glucose monitoring
• Diagnostic laboratory systems
• Cardiovascular medical devices
• Clinical nutrition products

Headquarters

HQ city

Illinois City

HQ country

United States

HQ region

North America

Offices13 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Devices (Cardiovascular, Diabetes, Neuromodulation): Sales of implantable medical devices, diagnostic equipment, and monitoring systems to healthcare providers and directly to consumers
2. Diagnostics: Laboratory diagnostic systems, rapid point-of-care tests, and molecular diagnostic products sold to hospitals, labs, and consumers
3. Nutrition Products: Infant formula, nutritional supplements, and specialized nutrition products sold through retail and direct channels
4. Medicines for Emerging Markets: Pharmaceutical products including women's health, cardiometabolic, gastroenterology, and oncology medicines sold in emerging markets
5. Established Pharmaceuticals: Branded generic and prescription pharmaceutical products across multiple therapeutic areas

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Abbott is a diversified healthcare company that develops, manufactures, and sells medical devices, diagnostic systems, nutrition products, and branded pharmaceutical products across more than 160 countries. Its portfolio spans continuous glucose monitoring (FreeStyle Libre, Lingo), cardiovascular and structural heart devices (MitraClip, HeartMate 3, pacemakers, CardioMEMS), diagnostic instruments (Alinity, ARCHITECT, BinaxNOW, ID NOW, i-STAT), neuromodulation systems for chronic pain and movement disorders, and consumer nutrition brands (Similac, Ensure, Pedialyte, PediaSure, Glucerna, EleCare, PROTALITY). The company serves more than 2 billion people globally through healthcare providers, retail, pharmacies, and direct e-commerce channels.

Product overview

Abbott is a diversified healthcare company offering a broad portfolio of products and solutions spanning six core business segments: Diabetes Care (FreeStyle Libre continuous glucose monitoring, Lingo biowearable), Diagnostics (Alinity and ARCHITECT laboratory systems, BinaxNOW rapid tests, ID NOW molecular platform, i-STAT point-of-care testing), Cardiovascular (structural heart devices including MitraClip and TriClip, cardiac rhythm management with pacemakers and ICDs, heart failure solutions including HeartMate LVADs and CardioMEMS, electrophysiology mapping and ablation systems), Neuromodulation (spinal cord stimulation systems for chronic pain, deep brain stimulation for movement disorders), Nutrition (Ensure, Similac, Pedialyte, PediaSure, Glucerna, EleCare), and Medicines (established pharmaceuticals for emerging markets). The company operates across 160+ countries with 122,000 employees worldwide, providing life-changing health technologies serving billions of people globally.

Differentiator

Problem solved

Functional benefit

Brands

• FreeStyle Libre: Continuous glucose monitoring system for diabetes management
• Lingo
• BinaxNOW
• Similac
• Ensure
• Pedialyte
• PediaSure
• Glucerna
• MitraClip
• HeartMate
• Alinity
• ID NOW

Products and services

• FreeStyle Libre Continuous Glucose Monitoring System Continuous glucose monitoring system for people with diabetes, providing real-time glucose readings without fingersticks using a factory-calibrated 15-day sensor.
• Lingo Biowearable Glucose System Biowearable glucose monitoring system for health-conscious adults 18+ not on insulin, providing personalized coaching that translates glucose data into actionable health insights for energy, weight, and athletic performance.
• BinaxNOW COVID-19/Flu A&B Combo Self Test Rapid at-home antigen test for detecting COVID-19 and influenza A&B, providing results in 15 minutes.
• BinaxNOW COVID-19/Flu A&B Professional Use Test Professional-use rapid antigen test for detecting COVID-19 and influenza A&B in clinical settings.
• ID NOW Rapid Molecular Platform Rapid molecular testing platform for point-of-care infectious disease detection in clinical settings.
• i-STAT 1 Point-of-Care Analyzer Point-of-care diagnostic device for blood analysis including blood gases, electrolytes, coagulation, and cardiac markers.
• Alinity ci-series Clinical Chemistry and Immunoassay System Integrated clinical chemistry and immunoassay diagnostic system for laboratory testing in clinical laboratories.
• Alinity h-series Hematology System Hematology system for complete blood count analysis in clinical laboratories.
• Alinity m Molecular Diagnostic Instrument Molecular diagnostic instrument for infectious disease testing in clinical laboratories.
• ARCHITECT Clinical Chemistry Analyzers Clinical chemistry analyzers for laboratory-based diagnostic testing.
• ARCHITECT Immunoassay Analyzers Immunoassay analyzers for detecting and measuring specific substances including hormones, tumor markers, and infectious disease markers.
• MitraClip Transcatheter Mitral Valve Repair System Transcatheter device for minimally invasive mitral valve repair in patients with mitral regurgitation, avoiding open-heart surgery.
• TriClip Transcatheter Tricuspid Valve Repair System Transcatheter system for tricuspid valve repair in patients with tricuspid regurgitation.
• Navitor TAVI System Transcatheter aortic valve implantation system for treating aortic stenosis.
• Amplatzer Amulet LAA Occluder Left atrial appendage closure device for stroke risk reduction in patients with atrial fibrillation.
• HeartMate 3 Left Ventricular Assist Device Mechanical circulatory support device for advanced heart failure patients.
• CardioMEMS HF System Pulmonary artery pressure monitoring system for managing heart failure patients.
• AVEIR DR Dual Chamber Leadless Pacemaker System Leadless dual-chamber pacemaker system for treating bradycardia.
• Assert-IQ Insertable Cardiac Monitor Insertable cardiac monitor for detecting arrhythmias and monitoring cardiac rhythm.
• EnSite X EP System Cardiac mapping system for electrophysiology procedures and ablation planning.
• Volt PFA System Pulse field ablation system for treating atrial fibrillation.
• TactiFlex Ablation Catheter Sensor-enabled irrigated ablation catheter for cardiac ablation procedures.
• Proclaim Plus Recharge-free SCS System Spinal cord stimulation system for treating chronic pain without requiring recharging.
• Eterna Rechargeable SCS System Rechargeable spinal cord stimulation system for chronic pain management.
• Infinity DBS System Deep brain stimulation system for treating movement disorders including Parkinson's disease.
• Liberta RC System Rechargeable deep brain stimulation system for movement disorders.
• Ensure Adult Nutrition Complete, balanced nutrition supplements for adults 18+ to support muscle health, immune function, and overall wellness, including Ensure Original, Ensure Plus, and Ensure Clear variants.
• Similac Infant Formula Infant formula products designed to support baby growth and development from birth onward, including Similac Pro Advance, Similac Total Comfort, and Similac Sensitive.
• Pedialyte Hydration Products Oral hydration solutions for children and adults to replace fluids and electrolytes lost during illness or activity, including Pedialyte Powder Packs and Pedialyte Sports.
• PediaSure Pediatric Nutrition Complete nutrition for children at risk for malnutrition or who need supplemental nutrition support, including PediaSure Grow and Gain and PediaSure SideSweets.
• Glucerna Diabetes Nutrition Nutrition shakes and products specifically designed for people with diabetes to help manage blood sugar, including Glucerna Hunger Smart and Glucerna Shake.
• EleCare Amino Acid-Based Formula Amino acid-based elemental formula for infants and children with severe food allergies or digestive issues.
• PROTALITY Nutrition Shake Nutrition shake for adults focused on muscle health and weight management.

Quantifiable outcome

• Serves more than 2 billion people globally
• +1 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Global SupplierscoreOthersAbbott collaborates with innovators across the world to develop new and better products for improved health. The company holds suppliers to the highest standards of quality and safety, recognizing that people all over the world depend on Abbott products.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medtronic: Largest pure-play medical device competitor with overlapping cardiovascular, cardiac rhythm, neuromodulation (DBS/SCS), and diabetes adjacencies. Comparable diversified device portfolio across therapeutic areas.
• Stryker: Medical device peer with comparable hospital-channel sales motion and overlapping surgical/med-surgical categories, particularly in procedural care.
• Edwards Lifesciences: Primary competitor in transcatheter heart valves and structural heart — directly contests MitraClip/TriClip with PASCAL and competes in TAVI with Navitor.
• Becton, Dickinson and Company (BD): Medical device and diagnostics peer with overlapping point-of-care testing, vascular access, and clinical lab product portfolios.
• Boston Scientific: Direct competitor across cardiovascular, peripheral vascular, cardiac rhythm management, and neuromodulation franchises. Most head-to-head overlap with Abbott in EP and structural heart.
• Dexcom: Direct competitor in continuous glucose monitoring, going head-to-head with FreeStyle Libre in both diabetes and consumer metabolic health segments.

Broad incumbents

• Thermo Fisher Scientific: Major life sciences and diagnostics peer with comparable instrument platforms, immunoassay, and clinical chemistry offerings that intersect Abbott's diagnostics business.
• Roche: Diagnostics powerhouse with overlapping central laboratory, point-of-care, and molecular testing franchises (vs Abbott's Alinity/ARCHITECT/ID NOW), plus pharmaceutical adjacencies.
• Johnson & Johnson: Diversified healthcare giant with medical devices, pharmaceuticals, and consumer health divisions that overlap with Abbott across cardiovascular, vision, orthopedics, and consumer nutrition.
• Danaher: Diversified life sciences and diagnostics conglomerate (Beckman Coulter, Cepheid, Leica, Radiometer) competing with Abbott in clinical lab instruments and molecular diagnostics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AbbottNews
• Facebookfacebook.com/Abbott

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott